10x Genomics, Inc. (NASDAQ: TXG) experienced a notable uptick of 5.19%, reaching $45.03 in the extended trading session on Tuesday. During the regular session, the
On February 16, 10x Genomics Inc. (TXG) posted results for its fourth quarter and full-year 2021. Missed earnings and revenue caused the stock to plunge
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.